Ultrastructural analysis and electron microscopic localization of Nox4 in healthy and atherosclerotic human aorta

Ultrastructural Pathology

Volumn 35, Issue 1, 2011, Pages 1-6

  Perrotta, Ida ^a   Sciangula, Alfonso ^b   Perrotta, Enrico ^a   Donato, Giuseppe ^c   Cassese, Mauro ^b  

^a UNIVERSITY OF CALABRIA   (Italy)

^b Sant'Anna Hospital   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Differentiation atherosclerosis; NADPH oxidase 4; Vascular smooth muscle cells

Indexed keywords

NOX4 PROTEIN, HUMAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

AORTA; ARTICLE; ATHEROSCLEROSIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; VASCULAR SMOOTH MUSCLE;

AORTA; ATHEROSCLEROSIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; NADPH OXIDASE;

EID: 79251591938     PISSN: 01913123     EISSN: 15210758     Source Type: Journal    
DOI: 10.3109/01913123.2010.510261     Document Type: Article

References (39)

1. Burdon RH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Rad Biol Med. 1995; 18: 775-794.
2. Arnold RS, Shi J, Murad E, et al. Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1. Proc Natl Acad Sci USA. 2001; 98: 5550-5555.
3. Yamaura M, Mitsushita J, Furuta S, et al. NADPH oxidase 4 contributes to transformation phenotype of melanoma cells by regulating G2-M cell cycle progression. Cancer Res. 2009; 15: 2647-2654.
4. Rensen SS, Doevendans PA, van Eys GJ. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth Heart J. 2007; 15: 100-108.
5. Stegemann JP, Hong H, Nerem RM. Mechanical, biochemical, and extracellular matrix effects on vascular smooth muscle cell phenotype. J Appl Physiol. 2005; 98: 2321-2327.
6. Perrotta I, Brunelli E, Sciangula A, et al. Inducible and endothelial nitric oxide synthase expression in human atherogenesis: an immunohistochemical and ultrastructural study. Cardiovasc Pathol. 2009; 18: 361-368.
7. Mulvihill ER, Jaeger J, Sengupta R, et al. Atherosclerotic plaque smooth muscle cells have a distinct phenotype. Arterioscler Thromb Vasc Biol. 2004;24:1283-1289
8. Patel R, Cardneau JD, Colles SM, Graham LM. Synthetic smooth muscle cell phenotype is associated with increased nicotinamide adenine dinucleotide phosphate oxidase activity: effect on collagen secretion. J Vasc Surg. 2006; 43: 364-371.
9. Ushio-Fukai M, Zafari AM, Fukui T, Ishizata N, Griendling KK. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem. 1996; 271: 23317-23321.
10. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007; 87: 245-313.
11. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, Griendling KK. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2004;24:677-683
12. de Carvalho DD, Sadok A, Bourgarel-Rey V, et al. Nox1 downstream of 12-lipoxygenase controls cell proliferation but not cell spreading of colon cancer cells. Int J Cancer. 2008;122:1757-1764
13. Dammanahalli K, Sun Z. Endothelin (ET)-1 inhibits nicotinamide adenine dinucleotide phosphate oxidase activity in human abdominal aortic endothelial cells: a novel function of ETB1 receptors. Endocrinology. 2008;149:4979-4987
14. Mitsushita J, Lambeth D, Kamata T. The superoxide-generating oxidase Nox1 is functionally required for Ras oncogene transformation. Cancer Res. 2004; 64: 3580-3585.
15. Clempus RE, Sorescu D, Dikalova AE, et al. Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol. 2007; 27: 42-48.
16. Cucoranu I, Clempus R, Dikalova A, et al. NAD(P)H oxidase 4 mediates transforming growth factor-β1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res. 2005; 97: 900-907.
17. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004; 84: 767-801.
18. Tsai MC, Chen L, Zhou J, et al. Shear stress induces synthetic-to- contractile phenotypic modulation in smooth muscle cells via peroxisome proliferator-activated receptor / activations by prostacyclin released by sheared endothelial cells. Circ Res. 2009; 105: 471-480.
19. Shekhonin BV, Rukosuev VS. Role of smooth-muscle cells in the formation of the atherosclerotic plaque. Bull Exp Biol Med. 2004; 79: 708-710.
20. Thyberg J, Blomgren K, Roy J, Tran PK, Hedin U. Phenotypic modulation of smooth muscle cells after arterial injury is associated with changes in the distribution of laminin and fibronectin. J Histochem Cytochem. 1997; 45: 837-846.
21. Rao RN, Falls DG, Gerrity RG, Sethuraman SN, Thiruvaiyaru DS, PDAY Group. Intimal thickness and layering, and smooth muscle cell phenotypes in aorta of youth. Pathobiology. 2000; 68: 18-28.
22. Scandalios JG. Oxidative stress response - what genome scale-studies taught us. Genome Biol. 2002; 3: 1-6.
23. Su B, Mitra S, Gregg H, et al. Redox regulation of vascular smooth muscle cell differentiation. Circ Res. 2001; 89: 39-46.
24. King MR, Ismail AS, Davis LS, Karp RD. Oxidative stress promotes polarization of human T cell differentiation toward a Thelper 2 phenotype. J Immunol. 2006; 176: 2765-2772.
25. Baia XC, Lua D, Baib J, et al. Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-κB. Biochem Biophys Res Commun. 2004; 314: 197-207.
26. Larbi A, Kempf J, Pawelec G. Oxidative stress modulation and T cell activation. Exp Gerontol 2007; 42: 852-858.
27. Brandes RP, Schröder K. Differential vascular functions of Nox family NADPH oxidases. Curr Opin Lipidol. 2008; 19: 513-518.
28. Geiszt M, Kopp JB, Varnai P, Leto TL. (2000) Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci USA. 2000; 97: 8010-8014.
29. Shiose A, Kuroda J, Tsuruya K, et al. A novel superoxide-producing NAD(P)H oxidase in kidney. J Biol Chem. 2001;276:1417-1423
30. Gorin Y, Ricono JM, Kim NH, Bhandari B, Choudhury GG, Abboud HE. Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells. Am J Physiol Renal Physiol. 2003; 285: F219-F229.
31. Carmona-Cuenca I, Roncero C, Sancho P, et al. Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity. J Hepatol. 2008; 49: 965-976.
32. Basuroy S, Bhattacharya S, Leffler CW, Parfenova H. Nox4 NADPH oxidase mediates oxidative stress and apoptosis caused by TNF-in cerebral vascular endothelial cells. Am J Physiol Cell Physiol. 2009; 296: C422-C432.
33. Stielow C, Muller G, Goettsch W, Wagner A, Morawietz H. Abstract 700: AP-1-mediated downregulation of Nox4 promoter activity by laminar shear stress in human endothelial cells. Circulation. 2006; 114(Suppl): II-119.
34. Blocka K, Gorina Y, Abbouda HE. Subcellular localization of Nox4 and regulation in diabetes. Proc Natl Acad Sci USA. 2009; 106: 14385-14390.
35. Mittal M, Roth M, König P, et al. Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature. Circ Res. 2007; 101: 258-267.
36. Ago T, Kuroda J, Hsu CP, Zhai P, Pain J, Sadoshima J. Abstract 1600: Endogenous Nox4 is protective during ischemia/reperfusion in the heart. Circulation. 2008; 118: S355.
37. Clempus RE, Sorescu D, Dikalova AE, et al. Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol. 2007; 27: 42-48.
38. Sorescu D, Weiss D, Lassègue B, et al. Superoxide production and expression of NOX family proteins in human atherosclerosis. Circulation. 2002; 105: 1429-1435.
39. Yang S, Zhang Y, Ries W, Key L. Expression of Nox4 in osteoclasts. J Cell Biochem. 2004; 92: 238-248.